Search for a report

GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028

GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028

The global nasal spray market is expected to reach $45.40 billion by 2028, growing at a CAGR of 9.39% during the forecast period. The base year considered for the study is 2020, and the estimated period is between 2021 and 2028. The market study has also analyzed the impact of COVID-19 on the nasal spray industry qualitatively and quantitatively.

GLOBAL NASAL SPRAY MARKET FORECAST 2021-2028

Global Nasal Spray Market by Product (Decongestion Nasal Spray, Steroid Nasal Spray, Saltwater Solution/saline Nasal Spray) Market by Prescription (Over the Counter, Prescribed) Market by Therapeutic (Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor) Market by Application (Nasal Congestion, Allergic and Non-allergic Rhinitis, Vaccination, CNS Disorders, Other Applications) Market by End-user (Home Care Setting, ASC/clinics, Pharmacy, Hospital, Other End-users) by Geography.

Request free sample

The global nasal spray market is expected to reach $45.40 billion by 2028, growing at a CAGR of 9.39% during the forecast period. The base year considered for the study is 2020, and the estimated period is between 2021 and 2028. The market study has also analyzed the impact of COVID-19 on the nasal spray industry qualitatively and quantitatively. 

To know more about this report, request a free sample copy.

Key enablers of the global nasal spray market growth are:

  • Rising acceptance in self-administration of medication
    • Self-medication is widespread in many nations. In recent years, the disparities in healthcare, medical remedies, and treatments have led to an increasing number of people choosing to self-medicate with over-the-counter drugs rather than see a doctor, particularly during the COVID-19 crisis.
    • As most patients are not qualified medical practitioners, they require delivery methods that are straightforward to use. The patients’ acceptability of self-administration rose as a result of nasal sprays’ simple delivery mechanism.
  • Rising adoption of nasal sprays due to easy administration methods
  • Increasing intranasal vaccines for COVID-19

Key factors restraining the market growth are:

  • Overuse risks associated with nasal sprays
    • Many nasal spray medicines are easily available for purchase over-the-counter. However, continued use of these drugs can aggravate symptoms such as breathing difficulties and damage to the nose. In addition, patients who take nasal sprays daily are prone to overdosing on the medications.
    • Nasal spray overuse can also cause headaches, coughing, nasal channel swelling (inflammation), and an increased risk of sinus infection, which has become a commercial challenge.

The report on the global nasal spray market includes the segmentation analysis of product, prescription, therapeutic, application, and end-user.

Market by Product:

  • Saltwater Solution/Saline Nasal Spray
    • Saltwater solution/saline nasal spray is anticipated to be the fastest-growing product in the market. Saline nasal sprays aid in the health of the cilia of the nose. Cilia are tiny hair-like structures that assist in humidifying the air that enters the lungs. They also trap germs to prevent them from entering the cells, improving the sense of smell. By maintaining the cilia healthy, saline sprays can help cure rhinitis and sinusitis.
    • During the COVID-19 pandemic, several people developed Mucormycosis, a severe fungal illness commonly known as Black Fungus. As fungus cannot grow in a saline environment, the saline nasal spray can be used as a prophylactic treatment for Mucormycosis.
  • Decongestion Nasal Spray
  • Steroid Nasal Spray

Geographically, the global nasal spray market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Russia, Belgium, Poland, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is anticipated to be the fastest-growing region in the global market, projecting a CAGR of 10.18%. As the Asia-Pacific is one of the world’s most densely inhabited regions, allergic illnesses have skyrocketed. Allergic Rhinitis (AR) is becoming more prevalent in Asia-Pacific countries. Similarly, asthma has grown more frequently in the Asia-Pacific area. Tobacco use, infection, and air pollution are the leading causes of respiratory disease and mortality.
    • Furthermore, the rising air pollution has led to a rise in respiratory disorders in some regions. Because of the growing elderly population, people in the countries such as Japan, Thailand, and South Korea are more vulnerable to respiratory diseases. These aspects are propelling the nasal spray market forward.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global nasal spray market are:

  • GlaxoSmithKline Plc
  • Proctor & Gamble Co
  • Johnson & Johnson
  • Pfizer Inc
  • Sun Pharmaceuticals Industries Ltd
  • Novartis International AG

Key strategies adopted by some of these companies:

In February 2021, Teva announced the sale of its OTC brand portfolio to Karo Pharma for €84 million. In May 2021, Catalent purchased Promethera’s cell therapy manufacturing business, including its facility in Gosselies, Belgium, for Commercial-Scale pDNA production.

Key findings of the nasal spray market:

  • Esketamine nasal spray is an efficient and fast-acting therapy for treatment-resistant depression. SPRAVATO (esketamine) CIII nasal spray was introduced by Johnson & Johnson’s Janssen Pharmaceutical Companies in 2020. SPRAVATO is the first and only authorized drug that has been shown to be effective against depression symptoms within 24 hours, offering a new alternative for considerable symptom alleviation.
  • According to the World Health Organization (WHO), there are an estimated 422 million diabetics worldwide. In 2020, Eli Lilly Canada Inc. launched Baqsimi nasal spray in Canada. The new nasal spray contains glucagon powder, a hormone that causes blood sugar levels to rise. The nasal spray is virtually as successful as other choices in this category.
  • With the ongoing COVID-19 pandemic, pharmaceutical firms are investigating second-generation technologies that might alter how vaccination doses are delivered and distributed. Many pharmaceuticals companies are working on nasal spray vaccines. Rokote Laboratories Finland Ltd, for example, has developed a nasal spray COVID-19 vaccination that employs gene transfer technology.

 

Frequently Asked Questions (FAQs):

  • Which nasal spray is used for the treatment of endometriosis?

A: Nafarelin nasal spray is used for the treatment of endometriosis.

  • Which is the prominent therapeutic in the nasal spray market?

A: Antihistamine is the prominent therapeutic in the nasal spray market.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RISING ADOPTION OF NASAL SPRAYS AMONG PATIENTS
      • GROWING ACCEPTANCE OF SELF-MEDICATION
      • INCREASING INTRANASAL VACCINES FOR COVID-19
    • KEY RESTRAINTS
      • OVERUSE RISKS ASSOCIATED WITH NASAL SPRAYS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON NASAL SPRAY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • STEROID NASAL SPRAY
    • SALTWATER SOLUTION/SALINE NASAL SPRAY
  3. MARKET BY PRESCRIPTION
    • OVER THE COUNTER
    • PRESCRIBED
  4. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • NASAL STEROIDS
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
  5. MARKET BY APPLICATION
    • NASAL CONGESTION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • VACCINATION
    • CNS DISORDERS
    • OTHER APPLICATIONS
  6. MARKET BY END-USER
    • HOME CARE SETTING
    • ASC/CLINICS
    • PHARMACY
    • HOSPITAL
    • OTHER END-USERS
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF THE WORLD
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PARTNERSHIPS & AGREEMENTS
    • COMPANY PROFILES
      • AKORN INCORPORATED
      • ALLERGAN PLC
      • APOTEX INC
      • BHARAT BIOTECH
      • CATALENT INC
      • CIPLA LIMITED
      • GLAXOSMITHKLINE PLC
      • JOHNSON & JOHNSON
      • NOVARTIS INTERNATIONAL AG
      • PFIZER INC
      • PROCTOR & GAMBLE CO (P&G)
      • SANOTIZE RESEARCH AND DEVELOPMENT
      • SUN PHARMACEUTICALS INDUSTRIES LTD
      • TEVA PHARMACEUTICALS INDUSTRIES LTD
      • VIATRIS

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NASAL SPRAY

TABLE 2: GLOBAL NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL DECONGESTION NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL DECONGESTION NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL STEROID NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL STEROID NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL SALTWATER SOLUTION/SALINE NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL SALTWATER SOLUTION/SALINE NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL OVER THE COUNTER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL OVER THE COUNTER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL PRESCRIBED MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL PRESCRIBED MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL ANTIHISTAMINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL ANTIHISTAMINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL NASAL STEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION

TABLE 21: GLOBAL NASAL STEROIDS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL ANTICHOLINERGIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL ANTICHOLINERGIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL MAST CELL INHIBITOR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL MAST CELL INHIBITOR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL NASAL CONGESTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL NASAL CONGESTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL VACCINATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL VACCINATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL CNS DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL CNS DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL HOME CARE SETTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL HOME CARE SETTING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL ASC/CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION

TABLE 43: GLOBAL ASC/CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 51: GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 52: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 53: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 54: KEY PLAYERS IN NORTH AMERICA NASAL SPRAY MARKET

TABLE 55: EUROPE NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 56: EUROPE NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 57: KEY PLAYERS IN EUROPE NASAL SPRAY MARKET

TABLE 58: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 59: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 60: KEY PLAYERS IN ASIA-PACIFIC NASAL SPRAY MARKET

TABLE 61: REST OF WORLD NASAL SPRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 62: REST OF WORLD NASAL SPRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 63: KEY PLAYERS IN REST OF WORLD NASAL SPRAY MARKET

TABLE 64: LIST OF MERGERS & ACQUISITIONS

TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

FIGURE 6: GLOBAL NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020

FIGURE 10: GLOBAL NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020

FIGURE 13: GLOBAL NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 18: GLOBAL NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 24: GLOBAL NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 27: GLOBAL NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 30: NORTH AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 31: UNITED STATES NASAL MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: CANADA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 34: UNITED KINGDOM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: GERMANY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: FRANCE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: ITALY NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: RUSSIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: BELGIUM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: POLAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: REST OF EUROPE NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: ASIA-PACIFIC NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 43: CHINA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: JAPAN NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: INDIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: SOUTH KOREA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: INDONESIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: THAILAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: VIETNAM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: AUSTRALIA AND NEW ZEALAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: REST OF ASIA-PACIFIC NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: REST OF THE WORLD NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 53: LATIN AMERICA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: MIDDLE EAST & AFRICA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • DECONGESTION NASAL SPRAY
    • STEROID NASAL SPRAY
    • SALTWATER SOLUTION/SALINE NASAL SPRAY
  2. MARKET BY PRESCRIPTION
    • OVER THE COUNTER
    • PRESCRIBED
  3. MARKET BY THERAPEUTIC
    • ANTIHISTAMINE
    • NASAL STEROIDS
    • ANTICHOLINERGIC
    • MAST CELL INHIBITOR
  4. MARKET BY APPLICATION
    • NASAL CONGESTION
    • ALLERGIC AND NON-ALLERGIC RHINITIS
    • VACCINATION
    • CNS DISORDERS
    • OTHER APPLICATIONS
  5. MARKET BY END-USER
    • HOME CARE SETTING
    • ASC/CLINICS
    • PHARMACY
    • HOSPITAL
    • OTHER END-USERS
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF THE WORLD
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now